Borrelia Afzelii Antigenfrom The Native Antigen Company |
|
NAT41583-100 | 0.1: 391.66 EUR | |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|
Borrelia Afzelii Antigenfrom The Native Antigen Company |
|
NAT41583-500 | 0.5: 1176.24 EUR | |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|
Borrelia Garinii Antigenfrom The Native Antigen Company |
|
NAT41584-100 | 0.1: 391.66 EUR | |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|
Borrelia Garinii Antigenfrom The Native Antigen Company |
|
NAT41584-500 | 0.5: 1176.24 EUR | |
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|
Brucella Abortus Antigenfrom The Native Antigen Company |
|
NAT41599-100 | 0.1: 391.66 EUR | |
Description: Brucella abortus lysate, produced by fermentation. |
|
Brucella Abortus Antigenfrom The Native Antigen Company |
|
NAT41599-500 | 0.5: 1176.24 EUR | |
Description: Brucella abortus lysate, produced by fermentation. |
|
Candida Albicans Antigenfrom The Native Antigen Company |
|
NAT41601-100 | 0.1: 391.66 EUR | |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|
Candida Albicans Antigenfrom The Native Antigen Company |
|
NAT41601-500 | 0.5: 1176.24 EUR | |
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|
Canine Parvovirus Antigenfrom The Native Antigen Company |
|
NAT41594-100 | 0.1: 391.66 EUR | |
Description: Canine Parvovirus, produced in CRFK cells. |
|
Canine Coronavirus Antigenfrom The Native Antigen Company |
|
NAT41590-100 | 0.1: 391.66 EUR | |
Description: Canine Coronavirus produced in A-72 cells. |
|
Feline Calicivirus Antigenfrom The Native Antigen Company |
|
NAT41595-100 | 0.1: 391.66 EUR | |
Description: Feline Calicivirus produced in FC 3TG cells. |
|
Helicobacter Pylori Antigenfrom The Native Antigen Company |
|
NAT41603-100 | 0.1: 391.66 EUR | |
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|
Helicobacter Pylori Antigenfrom The Native Antigen Company |
|
NAT41603-500 | 0.5: 1176.24 EUR | |
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|
Campylobacter Jejuni Antigenfrom The Native Antigen Company |
|
NAT41600-100 | 0.1: 391.66 EUR | |
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|
Campylobacter Jejuni Antigenfrom The Native Antigen Company |
|
NAT41600-500 | 0.5: 1176.24 EUR | |
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|
Chlamydia Trachomatis Antigenfrom The Native Antigen Company |
|
CT022-1000 | 1.0: 378.90 EUR | |
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
|
Mycoplasma Pneumoniae Antigenfrom The Native Antigen Company |
|
MP901-1000 | 1.0: 1010.39 EUR | |
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|
Mycoplasma Pneumoniae Antigenfrom The Native Antigen Company |
|
MP901-200 | 0.2: 270.46 EUR | |
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|
Echovirus Antigen, Recombinantfrom The Native Antigen Company |
|
REC31776-100 | 0.1: 276.84 EUR | |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|
Echovirus Antigen, Recombinantfrom The Native Antigen Company |
|
REC31776-500 | 0.5: 1043.56 EUR | |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|
Neisseria Gonorrhoeae Antigenfrom The Native Antigen Company |
|
NG01-1000 | 1.0: 378.90 EUR | |
Description: Homogenised lysate of pure bacteria. |
|
Trichomonas Vaginalis Antigenfrom The Native Antigen Company |
|
TV01-1000 | 1.0: 421.00 EUR | |
Description: Washed & lysed suspension of whole protozoa |
|
Enterovirus Antigen, Recombinantfrom The Native Antigen Company |
|
REC31772-100 | 0.1: 276.84 EUR | |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|
Enterovirus Antigen, Recombinantfrom The Native Antigen Company |
|
REC31772-500 | 0.5: 1043.56 EUR | |
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|
Echinococcus Granulosus Antigenfrom The Native Antigen Company |
|
NAT41602-100 | 0.1: 391.66 EUR | |
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|
Echinococcus Granulosus Antigenfrom The Native Antigen Company |
|
NAT41602-500 | 0.5: 1176.24 EUR | |
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|
Cytomegalovirus Purified Antigenfrom The Native Antigen Company |
|
CMV-HP-100 | 0.1: 318.94 EUR | |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|
Cytomegalovirus Purified Antigenfrom The Native Antigen Company |
|
CMV-HP-1000 | 1.0: 2096.06 EUR | |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|
Cytomegalovirus Purified Antigenfrom The Native Antigen Company |
|
CMV-HP-500 | 0.5: 1279.58 EUR | |
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|
Astrovirus Antigen (Type 1)from The Native Antigen Company |
|
AS02-1000 | 1.0: 1654.65 EUR | |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|
Astrovirus Antigen (Type 1)from The Native Antigen Company |
|
AS02-200 | 0.2: 442.69 EUR | |
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|
Yersinia pestis V antigenfrom The Native Antigen Company |
|
REC32028-100 | 0.1: 491.53 EUR | |
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|
Yersinia pestis V antigenfrom The Native Antigen Company |
|
REC32028-500 | 0.5: 2421.37 EUR | |
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|
Canine Herpes Virus Antigenfrom The Native Antigen Company |
|
NAT41592-100 | 0.1: 391.66 EUR | |
Description: Canine Herpes virus, produced in MDCK cells. |
|
Canine Adenovirus 1 Antigenfrom The Native Antigen Company |
|
NAT41587-100 | 0.1: 391.66 EUR | |
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
|
Canine Adenovirus 2 Antigenfrom The Native Antigen Company |
|
NAT41588-100 | 0.1: 391.66 EUR | |
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
|
Canine Distemper Virus Antigenfrom The Native Antigen Company |
|
NAT41591-100 | 0.1: 391.66 EUR | |
Description: Canine Distemper virus, produced in SL-29 cells. |
|
Norovirus GII.4 VP1 Antigenfrom The Native Antigen Company |
|
REC31620-100 | 0.1: 302.36 EUR | |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|
Norovirus GII.4 VP1 Antigenfrom The Native Antigen Company |
|
REC31620-1000 | 1.0: 1830.71 EUR | |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|
Norovirus GII.4 VP1 Antigenfrom The Native Antigen Company |
|
REC31620-500 | 0.5: 1066.53 EUR | |
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|
Canine Parainfluenza Virus Antigenfrom The Native Antigen Company |
|
NAT41593-100 | 0.1: 391.66 EUR | |
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|
Feline Panleukopenia Virus Antigenfrom The Native Antigen Company |
|
NAT41597-100 | 0.1: 391.66 EUR | |
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
|
Cytomegalovirus Cell Lysate Antigenfrom The Native Antigen Company |
|
CMV-CL-100 | 0.1: 223.26 EUR | |
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|
Cytomegalovirus Cell Lysate Antigenfrom The Native Antigen Company |
|
CMV-CL-1000 | 1.0: 1422.47 EUR | |
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|
Feline Viral Rhinotracheitis Antigenfrom The Native Antigen Company |
|
NAT41598-100 | 0.1: 391.66 EUR | |
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
|
Herpes Simplex Virus 1 Antigenfrom The Native Antigen Company |
|
HS105-1000 | 1.0: 1178.79 EUR | |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|
Herpes Simplex Virus 1 Antigenfrom The Native Antigen Company |
|
HS105-200 | 0.2: 294.70 EUR | |
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|
Herpes Simplex Virus 2 Antigenfrom The Native Antigen Company |
|
HS205-1000 | 1.0: 1178.79 EUR | |
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|
Herpes Simplex Virus 2 Antigenfrom The Native Antigen Company |
|
HS205-200 | 0.2: 294.70 EUR | |
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|
Ross River Virus Recombinant Antigenfrom The Native Antigen Company |
|
REC31969-100 | 0.1: 757.80 EUR | |
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|
Ross River Virus Recombinant Antigenfrom The Native Antigen Company |
|
REC31969-500 | 0.5: 2844.92 EUR | |
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|
Hepatitis B Virus E Antigen (HBeAg)from The Native Antigen Company |
|
REC31677-100 | 0.1: 456.72 EUR | |
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|
Hepatitis B Virus E Antigen (HBeAg)from The Native Antigen Company |
|
REC31677-500 | 0.5: 1941.06 EUR | |
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|
Canine Adenovirus 1 and 2 Antigenfrom The Native Antigen Company |
|
NAT41589-100 | 0.1: 391.66 EUR | |
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
|
Hepatitis B Virus Core Antigen (HBcAg)from The Native Antigen Company |
|
REC31689-100 | 0.1: 456.72 EUR | |
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|
Hepatitis B Virus Core Antigen (HBcAg)from The Native Antigen Company |
|
REC31689-500 | 0.5: 1370.16 EUR | |
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|
Hepatitis C Virus Core Antigen (HCcAg)from The Native Antigen Company |
|
REC31693-100 | 0.1: 484.79 EUR | |
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|
Hepatitis C Virus Core Antigen (HCcAg)from The Native Antigen Company |
|
REC31693-500 | 0.5: 1455.64 EUR | |
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|
Herpes Simplex Virus 1 Lysate Antigenfrom The Native Antigen Company |
|
HS104-1000 | 1.0: 270.46 EUR | |
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
|
Herpes Simplex Virus 2 Lysate Antigenfrom The Native Antigen Company |
|
HS204-1000 | 1.0: 270.46 EUR | |
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
|
Feline Infectious Peritonitis Virus Antigenfrom The Native Antigen Company |
|
NAT41596-100 | 0.1: 391.66 EUR | |
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
|
Legionella pneumophila antigen (native extract)from The Native Antigen Company |
|
NAT41580-100 | 0.1: 391.66 EUR | |
Description: Inactivated Legionella pneumophila antigen from culture. |
|
Leptospira Biflexa Antigen (Strain Patoc 1)from The Native Antigen Company |
|
NAT41582-100 | 0.1: 391.66 EUR | |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|
Leptospira Biflexa Antigen (Strain Patoc 1)from The Native Antigen Company |
|
NAT41582-500 | 0.5: 1176.24 EUR | |
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|
Streptococcus Pneumoniae Antigen, Native Extractfrom The Native Antigen Company |
|
NAT41604-100 | 0.1: 391.66 EUR | |
Description: Inactivated Streptococcus pneumoniae antigen from culture. |
|
Mouse Anti-Hepatitis B Surface Antigen Antibody (1834)from The Native Antigen Company |
|
MAB12230-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834). |
|
Mouse Anti-Hepatitis B Surface Antigen Antibody (1837)from The Native Antigen Company |
|
MAB12231-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837) |
|
Mouse Anti-Hepatitis B Surface Antigen Antibody (1838)from The Native Antigen Company |
|
MAB12232-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892)from The Native Antigen Company |
|
MAB12226-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893)from The Native Antigen Company |
|
MAB12227-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894)from The Native Antigen Company |
|
MAB12228-100 | 0.1: 275.56 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)from The Native Antigen Company |
|
MAB12298-100 | 0.1: 276.84 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132)from The Native Antigen Company |
|
MAB12298-500 | 0.5: 695.29 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)from The Native Antigen Company |
|
MAB12299-100 | 0.1: 276.84 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133)from The Native Antigen Company |
|
MAB12299-500 | 0.5: 695.29 EUR | |
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tagfrom The Native Antigen Company |
|
REC32027-100 | 0.1: 491.53 EUR | |
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tagfrom The Native Antigen Company |
|
REC32027-500 | 0.5: 2421.37 EUR | |
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|
Cancer Antigen 242 Antigenfrom Creative Biolabs |
|
VAng-Cr3876-10kU | 10 kU: 505.20 EUR | |
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration. |
|
CEA Antigen (Antigen Grade)from GenWay Biotech |
|
GWB-378447 | 1 mg: Ask for price | |
Cancer Antigen 50 Antigenfrom Creative Biolabs |
|
VAng-Cr3877-50kU | 50 kU: 6642.00 EUR | |
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|
Cancer Antigen 72-4 Antigenfrom Creative Biolabs |
|
VAng-Cr3878-10kU | 10 kU: 505.20 EUR | |
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|
Cancer Antigen 125 Antigen (Ascites Fluid)from Creative Biolabs |
|
VAng-Cr3870-10kU | 10 kU: 1132.80 EUR | |
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE. |
|
Cancer Antigen 125 Antigen (Human Adenocarcinoma)from Creative Biolabs |
|
VAng-Cr3868-10kU | 10 kU: 505.20 EUR | |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
|
Human carcinoembryonic antigen (CEA) antigenfrom Alpha Diagnostics |
|
CEA15-N-100 | 100 ug: 270.00 EUR | |
Cancer Antigen CEA Antigen (Human Fluids)from Creative Biolabs |
|
VAng-Wyb8644-inquire | inquire: Ask for price | |
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL. |
|
Cancer Antigen 19-9 Antigen (Liver Carcinoma)from Creative Biolabs |
|
VAng-Cr3873-10kU | 10 kU: 472.80 EUR | |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|
Tn antigen, Thomsen Friedenreich Tn antigenfrom ImmunoBioscience |
|
MM-1018-01 | 0.5 ml: 158.90 EUR | |
Tn antigen, Thomsen Friedenreich Tn antigenfrom ImmunoBioscience |
|
MM-1018-02 | 1.0 ml: 238.70 EUR |